drug
anti-thymocyte globulin (rabbit)
Marketedupdated 3mo agoby Genzyme Corp
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying anti-thymocyte globulin (rabbit)
- phase2The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients
- phase4Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR
- phase1Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
- phase2ATG Plus PTCy vs ATG for CGVHD Prophylaxis
- phase2A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant
- phase2PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM
- phase4Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation
News(1)
- Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independenceAfter the trailblazing approval of Sanofi’s Tzield for stage 3 type 1 diabetes, several companies, including SAB Biotherapeutics and Eledon Pharmaceuticals, are vying for a spot in the landscape wi…biospace · 26d ago
Data sources
last refreshed just now
Found something off?
comments(0)
5-min edit window · permanent after that